Cargando…

Diabetes mellitus and the risk of bladder cancer: an Italian case–control study

BACKGROUND: Diabetes mellitus has been associated with an increased risk of bladder cancer, although the evidence is still open to discussion. METHODS: We examined this association using data from a multicentre Italian case–control study, conducted between 2003 and 2014 on 690 bladder cancer cases a...

Descripción completa

Detalles Bibliográficos
Autores principales: Turati, F, Polesel, J, Di Maso, M, Montella, M, Libra, M, Grimaldi, M, Tavani, A, Serraino, D, La Vecchia, C, Bosetti, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647534/
https://www.ncbi.nlm.nih.gov/pubmed/25996204
http://dx.doi.org/10.1038/bjc.2015.178
_version_ 1782401119960432640
author Turati, F
Polesel, J
Di Maso, M
Montella, M
Libra, M
Grimaldi, M
Tavani, A
Serraino, D
La Vecchia, C
Bosetti, C
author_facet Turati, F
Polesel, J
Di Maso, M
Montella, M
Libra, M
Grimaldi, M
Tavani, A
Serraino, D
La Vecchia, C
Bosetti, C
author_sort Turati, F
collection PubMed
description BACKGROUND: Diabetes mellitus has been associated with an increased risk of bladder cancer, although the evidence is still open to discussion. METHODS: We examined this association using data from a multicentre Italian case–control study, conducted between 2003 and 2014 on 690 bladder cancer cases and 665 frequency-matched hospital controls. Odds ratios (ORs) for diabetes were estimated by unconditional multiple logistic regression models, after allowance for major known risk factors for bladder cancer. RESULTS: One hundred and twelve (16.2%) cases and 57 (8.6%) controls reported a diagnosis of diabetes mellitus, corresponding to a multivariate OR of 2.09 (95% confidence interval (CI): 1.46–3.01). Bladder cancer risk increased with duration of diabetes (OR 1.92 for 1–<5 years, 1.63 for 5–<10 years, 2.39 for 10–<15 years, and 2.58 for ⩾15 years). The increased risk of bladder cancer was consistent in strata of age and education, whereas it was somewhat lower (although not significantly) in women (OR 1.18), in never (OR 1.31) and current (OR 1.42) smokers, and in subjects with a body mass index <25 kg m(−2) (OR 1.48). CONCLUSION: The present study provides further support of a role of diabetes in bladder cancer aetiology, although some residual confounding by tobacco, body mass index, or other unmeasured covariates may partly explain the association observed.
format Online
Article
Text
id pubmed-4647534
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-46475342016-06-30 Diabetes mellitus and the risk of bladder cancer: an Italian case–control study Turati, F Polesel, J Di Maso, M Montella, M Libra, M Grimaldi, M Tavani, A Serraino, D La Vecchia, C Bosetti, C Br J Cancer Epidemiology BACKGROUND: Diabetes mellitus has been associated with an increased risk of bladder cancer, although the evidence is still open to discussion. METHODS: We examined this association using data from a multicentre Italian case–control study, conducted between 2003 and 2014 on 690 bladder cancer cases and 665 frequency-matched hospital controls. Odds ratios (ORs) for diabetes were estimated by unconditional multiple logistic regression models, after allowance for major known risk factors for bladder cancer. RESULTS: One hundred and twelve (16.2%) cases and 57 (8.6%) controls reported a diagnosis of diabetes mellitus, corresponding to a multivariate OR of 2.09 (95% confidence interval (CI): 1.46–3.01). Bladder cancer risk increased with duration of diabetes (OR 1.92 for 1–<5 years, 1.63 for 5–<10 years, 2.39 for 10–<15 years, and 2.58 for ⩾15 years). The increased risk of bladder cancer was consistent in strata of age and education, whereas it was somewhat lower (although not significantly) in women (OR 1.18), in never (OR 1.31) and current (OR 1.42) smokers, and in subjects with a body mass index <25 kg m(−2) (OR 1.48). CONCLUSION: The present study provides further support of a role of diabetes in bladder cancer aetiology, although some residual confounding by tobacco, body mass index, or other unmeasured covariates may partly explain the association observed. Nature Publishing Group 2015-06-30 2015-05-21 /pmc/articles/PMC4647534/ /pubmed/25996204 http://dx.doi.org/10.1038/bjc.2015.178 Text en Copyright © 2015 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Epidemiology
Turati, F
Polesel, J
Di Maso, M
Montella, M
Libra, M
Grimaldi, M
Tavani, A
Serraino, D
La Vecchia, C
Bosetti, C
Diabetes mellitus and the risk of bladder cancer: an Italian case–control study
title Diabetes mellitus and the risk of bladder cancer: an Italian case–control study
title_full Diabetes mellitus and the risk of bladder cancer: an Italian case–control study
title_fullStr Diabetes mellitus and the risk of bladder cancer: an Italian case–control study
title_full_unstemmed Diabetes mellitus and the risk of bladder cancer: an Italian case–control study
title_short Diabetes mellitus and the risk of bladder cancer: an Italian case–control study
title_sort diabetes mellitus and the risk of bladder cancer: an italian case–control study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647534/
https://www.ncbi.nlm.nih.gov/pubmed/25996204
http://dx.doi.org/10.1038/bjc.2015.178
work_keys_str_mv AT turatif diabetesmellitusandtheriskofbladdercanceranitaliancasecontrolstudy
AT poleselj diabetesmellitusandtheriskofbladdercanceranitaliancasecontrolstudy
AT dimasom diabetesmellitusandtheriskofbladdercanceranitaliancasecontrolstudy
AT montellam diabetesmellitusandtheriskofbladdercanceranitaliancasecontrolstudy
AT libram diabetesmellitusandtheriskofbladdercanceranitaliancasecontrolstudy
AT grimaldim diabetesmellitusandtheriskofbladdercanceranitaliancasecontrolstudy
AT tavania diabetesmellitusandtheriskofbladdercanceranitaliancasecontrolstudy
AT serrainod diabetesmellitusandtheriskofbladdercanceranitaliancasecontrolstudy
AT lavecchiac diabetesmellitusandtheriskofbladdercanceranitaliancasecontrolstudy
AT bosettic diabetesmellitusandtheriskofbladdercanceranitaliancasecontrolstudy